PRIYA RASTOGI

PITTSBURGH, PA NPI 1790750289

General Payments — all program years on this page

$24,215.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 61
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $13,859.39 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $12,717.507
Travel and Lodging $766.453
Food and Beverage $375.446

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
AstraZeneca UK Limited $11,131.8914
Daiichi Sankyo Inc. $1,387.501
Acerta Pharma LLC $1,340.001

By program year

Program yearAmountRecords
2018 $4,203.4013
2019 $1,289.3517
2020 $1,931.372
2021 $11.921
2022 $474.896
2023 $2,445.206
2024 $13,859.3916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089472689 Daiichi Sankyo Inc. $1,387.50 01/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110532447 AstraZeneca UK Limited $30.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110533640 AstraZeneca UK Limited $1,110.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110534318 AstraZeneca UK Limited $120.54 01/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110534426 AstraZeneca UK Limited $59.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110535378 AstraZeneca UK Limited $1,387.50 02/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110537811 AstraZeneca UK Limited $6,660.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110540337 AstraZeneca UK Limited $135.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110541149 AstraZeneca UK Limited $277.50 07/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110542695 AstraZeneca Pharmaceuticals LP $1,340.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110543515 AstraZeneca UK Limited $21.44 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110545749 AstraZeneca UK Limited $555.00 04/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110545947 AstraZeneca UK Limited $70.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110549518 AstraZeneca UK Limited $61.23 01/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110551214 AstraZeneca UK Limited $584.68 01/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110552092 AstraZeneca UK Limited $60.00 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.